Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trafficking protein particle complex subunit 2L (TRAPPC2L) is a highly conserved protein-coding gene that encodes a component of the TRAPP vesicle tethering complex[1][2][5]. The protein is structurally related to TRAPPC2, and both TRAPPC2L and TRAPPC2 are involved in vesicle-mediated transport, particularly from the endoplasmic reticulum to the Golgi apparatus. Knockdown of TRAPPC2L disrupts Golgi integrity, indicating its importance in membrane trafficking and Golgi dynamics[2][5]. TRAPPC2L is not classified as a classical therapeutic target such as a receptor, enzyme, or transporter. Mutations or disruptions to the gene have been associated with certain syndromic neurodevelopmental disorders but are not implicated as a direct cause of common diseases or used as a biomarker or therapeutic target in current clinical practice[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking protein particle complex subunit 2L (TRAPPC2L).